T1	CHEM 115 127	dolutegravir
#1	AnnotatorNotes T1	C3253985; dolutegravir; Organic Chemical · Pharmacologic Substance
T2	ANAT 131 136	semen
#2	AnnotatorNotes T2	C0036614; Seminal fluid; Body Substance | C2756969; Semen; Body Substance
T3	PROC 168 195	tratamiento antirretroviral
#3	AnnotatorNotes T3	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T4	CHEM 200 208	Abacavir
#4	AnnotatorNotes T4	C0663655; abacavir; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T5	CHEM 209 219	Lamivudina
#5	AnnotatorNotes T5	C0209738; lamivudine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T6	CHEM 224 236	Dolutegravir
#6	AnnotatorNotes T6	C3253985; dolutegravir; Organic Chemical · Pharmacologic Substance
T7	CHEM 330 342	dolutegravir
#7	AnnotatorNotes T7	C3253985; dolutegravir; Organic Chemical · Pharmacologic Substance
T8	ANAT 346 351	semen
#8	AnnotatorNotes T8	C0036614; Seminal fluid; Body Substance | C2756969; Semen; Body Substance
T9	PROC 383 410	tratamiento antirretroviral
#9	AnnotatorNotes T9	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T10	CHEM 415 423	Abacavir
#10	AnnotatorNotes T10	C0663655; abacavir; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T11	CHEM 424 434	Lamivudina
#11	AnnotatorNotes T11	C0209738; lamivudine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T12	CHEM 439 451	Dolutegravir
#12	AnnotatorNotes T12	C3253985; dolutegravir; Organic Chemical · Pharmacologic Substance
T13	DISO 491 510	Infección por VIH-1
#13	AnnotatorNotes T13	C2363741; HIV-1 infection; Disease or Syndrome
T14	DISO 591 618	Infección crónica por VIH-1
T15	PROC 640 667	tratamiento antirretroviral
#14	AnnotatorNotes T15	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T16	PROC 696 705	RNA VIH-1
T17	CHEM 696 699	RNA
#15	AnnotatorNotes T17	C0035668; RNA; Nucleic Acid, Nucleoside, or Nucleotide
T18	PROC 779 803	consentimiento informado
#16	AnnotatorNotes T18	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T19	PROC 865 888	métodos anticonceptivos
#17	AnnotatorNotes T19	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T20	PROC 1109 1114	HbsAg
#18	AnnotatorNotes T20	C0201477; Hepatitis B surface antigen measurement; Laboratory Procedure
T21	PROC 1036 1087	Marcadores serológicos de hepatitis crónica por VHB
#19	AnnotatorNotes T21	C2030661; serum hepatitis B markers; Laboratory Procedure
T22	DISO 1062 1087	hepatitis crónica por VHB
T23	DISO 1121 1142	Hepatitis crónica VHC
T24	PROC 1172 1183	tratamiento
#20	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	PROC 1291 1295	MDRD
#21	AnnotatorNotes T25	C1980036; Creatinine-based formula (MDRD); Laboratory Procedure
T26	DISO 1209 1231	Insuficiencia hepática
#22	AnnotatorNotes T26	C0085605; Liver Failure; Disease or Syndrome | C1306571; Hepatic Insufficiency; Pathologic Function
T27	DISO 1240 1259	Insuficiencia renal
#23	AnnotatorNotes T27	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T28	PROC 1261 1289	filtrado glomerular estimado
#24	AnnotatorNotes T28	C3811844; Estimated Glomerular Filtration Rate; Laboratory Procedure
T29	DISO 1309 1330	Infección oportunista
#25	AnnotatorNotes T29	C0029118; Opportunistic Infections; Disease or Syndrome
T30	DISO 1403 1408	VIH-1
#26	AnnotatorNotes T30	C2363741; HIV-1 infection; Disease or Syndrome
T31	DISO 1341 1350	Neoplasia
#27	AnnotatorNotes T31	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C1882062; Neoplastic disease; Neoplastic Process
T32	CHEM 1415 1441	fármacos antirretrovirales
#28	AnnotatorNotes T32	C0599685; Anti-Retroviral Agents; Pharmacologic Substance
T33	PROC 1460 1475	test genotípico
T34	PROC 1537 1559	pruebas de laboratorio
#29	AnnotatorNotes T34	C0022885; Laboratory Procedures; Laboratory Procedure
T35	PROC 72 93	carga viral del VIH-1
T36	PROC 287 308	carga viral del VIH-1
T37	CHEM 652 667	antirretroviral
#30	AnnotatorNotes T37	C0599685; Anti-Retroviral Agents; Pharmacologic Substance
T38	PROC 683 694	Carga viral
#31	AnnotatorNotes T38	C1261478; Viral load measurement; Laboratory Procedure
T39	PROC 746 756	HLA-B*5701
#32	AnnotatorNotes T39	C3203663; HLA-B*5701 assay; Laboratory Procedure
T40	ANAT 1223 1231	hepática
#33	AnnotatorNotes T40	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T41	ANAT 1254 1259	renal
#34	AnnotatorNotes T41	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T42	Observation 1378 1389	resistencia
#35	AnnotatorNotes T42	C3542449; Drug Resistance Status; Finding
T43	PROC 1594 1597	AST
#36	AnnotatorNotes T43	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T44	PROC 1600 1603	ALT
#37	AnnotatorNotes T44	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T45	PROC 1655 1666	bilirrubina
#38	AnnotatorNotes T45	C0863174; Blood bilirubin measurement; Laboratory Procedure
T46	Date 12 16	2013
T47	LIVB 140 149	pacientes
#39	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	LIVB 355 364	pacientes
#40	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	Age 561 587	igual o superior a 18 años
T50	Duration 601 608	crónica
#41	AnnotatorNotes T50	C0205191; chronic; Temporal Concept
T51	Neg_cue 622 624	No
T53	Duration 974 981	30 días
T55	Duration 1072 1079	crónica
#42	AnnotatorNotes T55	C0205191; chronic; Temporal Concept
T56	LIVB 1084 1087	VHB
#43	AnnotatorNotes T56	C0019169; hepatitis B virus; Virus
T57	Duration 1131 1138	crónica
#44	AnnotatorNotes T57	C0205191; chronic; Temporal Concept
T58	LIVB 1139 1142	VHC
#45	AnnotatorNotes T58	C0220847; hepatitis C virus; Virus
T59	Spec_cue 1157 1162	pueda
T63	LIVB 78 83	viral
#46	AnnotatorNotes T63	C0042776; Virus; Virus
T65	LIVB 293 298	viral
#47	AnnotatorNotes T65	C0042776; Virus; Virus
T66	LIVB 689 694	viral
#48	AnnotatorNotes T66	C0042776; Virus; Virus
T69	LIVB 88 93	VIH-1
#49	AnnotatorNotes T69	C0019704; HIV-1; Virus
T70	LIVB 303 308	VIH-1
#50	AnnotatorNotes T70	C0019704; HIV-1; Virus
T71	LIVB 505 510	VIH-1
#51	AnnotatorNotes T71	C0019704; HIV-1; Virus
T72	Neg_cue 365 370	naive
T73	LIVB 700 705	VIH-1
#53	AnnotatorNotes T73	C0019704; HIV-1; Virus
T62	LIVB 539 553	Sexo masculino
#54	AnnotatorNotes T62	C0025266; Male population group; Population Group
T52	PHYS 1261 1280	filtrado glomerular
#55	AnnotatorNotes T52	C0232809; Glomerular filtration; Organ or Tissue Function; Laboratory Procedure
T54	ANAT 1270 1280	glomerular
#56	AnnotatorNotes T54	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
T60	Neg_cue 150 155	naive
A1	Assertion T15 Negated
A2	Assertion T24 Speculated
A3	Status T3 History_of
A4	Assertion T3 Negated
A5	Status T9 History_of
A6	Assertion T9 Negated
A7	Status T15 History_of
A8	Status T4 History_of
A9	Assertion T4 Negated
A10	Status T5 History_of
A11	Assertion T5 Negated
A12	Status T6 History_of
A13	Assertion T6 Negated
A14	Status T12 History_of
A15	Assertion T12 Negated
A16	Status T11 History_of
A17	Assertion T11 Negated
A18	Status T10 History_of
A19	Assertion T10 Negated
#57	AnnotatorNotes T14	C2363741; HIV-1 infection; Disease or Syndrome + C0151317; Chronic Infection; Disease or Syndrome
#58	AnnotatorNotes T16	C4764103; HIV-1 RNA Measurement; Laboratory Procedure
#59	AnnotatorNotes T22	C0524909; Hepatitis B, Chronic; Disease or Syndrome
#60	AnnotatorNotes T23	C0524910; Hepatitis C, Chronic; Disease or Syndrome
#61	AnnotatorNotes T33	C2368152; virus genotyping; Laboratory Procedure 
#52	AnnotatorNotes T35	C5387829; HIV 1 antibody in serum, plasma or blood; Laboratory Procedure
#62	AnnotatorNotes T36	C5387829; HIV 1 antibody in serum, plasma or blood; Laboratory Procedure
R1	Experiences Arg1:T47 Arg2:T35	
R2	Negation Arg1:T60 Arg2:T3	
R3	Experiences Arg1:T47 Arg2:T3	
R4	Used_for Arg1:T4 Arg2:T3	
R5	Combined_with Arg1:T4 Arg2:T5	
R6	Combined_with Arg1:T5 Arg2:T6	
R7	Combined_with Arg1:T10 Arg2:T11	
R8	Combined_with Arg1:T11 Arg2:T12	
R9	Experiences Arg1:T48 Arg2:T36	
R10	Experiences Arg1:T48 Arg2:T9	
R11	Negation Arg1:T72 Arg2:T9	
R12	Used_for Arg1:T10 Arg2:T9	
R13	Causes Arg1:T71 Arg2:T13	
R14	Has_Duration_or_Interval Arg1:T14 Arg2:T50	
T61	LIVB 613 618	VIH-1
#63	AnnotatorNotes T61	C0019704; HIV-1; Virus
R15	Causes Arg1:T61 Arg2:T14	
R16	Negation Arg1:T51 Arg2:T15	
R17	Used_for Arg1:T37 Arg2:T15	
T64	Result_or_Value 707 722	>5000 copias/mL
R18	Has_Result_or_Value Arg1:T16 Arg2:T64	
R19	Has_Result_or_Value Arg1:T38 Arg2:T64	
T67	CONC 729 742	momento basal
#64	AnnotatorNotes T67	C1442488; Baseline; Quantitative Concept
R20	Overlap Arg1:T38 Arg2:T67	
R21	Overlap Arg1:T16 Arg2:T67	
T68	Result_or_Value 757 765	negativo
#65	AnnotatorNotes T68	C0205160; Negative; Finding
R22	Has_Result_or_Value Arg1:T39 Arg2:T68	
T74	CONC 816 825	inclusión
#66	AnnotatorNotes T74	C1512693; Inclusion; Qualitative Concept
R23	Before Arg1:T18 Arg2:T74	
T75	Observation 909 934	relaciones heterosexuales
#67	AnnotatorNotes T75	C0556476; Heterosxual relationship; Finding
R24	Overlap Arg1:T19 Arg2:T75	
T76	PROC 958 965	estudio
#68	AnnotatorNotes T76	C0008976; Clinical Trials; Research Activity
R25	Overlap Arg1:T75 Arg2:T76	
R26	Overlap Arg1:T19 Arg2:T76	
R27	Has_Duration_or_Interval Arg1:T19 Arg2:T53	
R28	After Arg1:T19 Arg2:T77	
T77	CONC 993 996	fin
#69	AnnotatorNotes T77	C4554101; Study Completion Date; Temporal Concept | C2983670; Study End Date; Temporal Concept
R29	Has_Duration_or_Interval Arg1:T22 Arg2:T55	
R30	Causes Arg1:T56 Arg2:T22	
T78	CONC 1094 1107	momento basal
#70	AnnotatorNotes T78	C1442488; Baseline; Quantitative Concept
R33	Overlap Arg1:T21 Arg2:T78	
R34	Overlap Arg1:T20 Arg2:T78	
R35	Causes Arg1:T58 Arg2:T23	
R36	Has_Duration_or_Interval Arg1:T23 Arg2:T57	
R37	Speculation Arg1:T59 Arg2:T24	
T79	PROC 1199 1206	estudio
#71	AnnotatorNotes T79	C0008976; Clinical Trials; Research Activity
R38	Overlap Arg1:T24 Arg2:T79	
R40	Location_of Arg1:T40 Arg2:T26	
T80	Quantifier_or_Qualifier 1232 1237	grave
#72	AnnotatorNotes T80	C1547227; Severe - Severity of Illness Code; Intellectual Product
R41	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T80	
R42	Location_of Arg1:T41 Arg2:T27	
R45	Location_of Arg1:T54 Arg2:T52	
R46	Location_of Arg1:T54 Arg2:T28	
R47	Location_of Arg1:T54 Arg2:T25	
T81	Result_or_Value 1297 1306	<60mL/min
R48	Has_Result_or_Value Arg1:T28 Arg2:T81	
R49	Has_Result_or_Value Arg1:T25 Arg2:T81	
T82	Quantifier_or_Qualifier 1331 1337	activa
#73	AnnotatorNotes T82	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R53	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T82	
T83	Quantifier_or_Qualifier 1351 1357	activa
#74	AnnotatorNotes T83	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R54	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T83	
R55	Overlap Arg1:T42 Arg2:T30	
R56	Overlap Arg1:T42 Arg2:T32	
T84	Quantifier_or_Qualifier 1390 1398	primaria
#75	AnnotatorNotes T84	C0205225; Primary; Qualitative Concept
R57	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T84	
T85	Quantifier_or_Qualifier 1476 1481	basal
#76	AnnotatorNotes T85	C1442488; Baseline; Quantitative Concept
R59	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T85	
T86	Observation 1508 1518;1530 1559	alteración en las pruebas de laboratorio
#77	AnnotatorNotes T86	C3648370; laboratory tests nonspecific abnormal findings; Finding (?)
T87	Quantifier_or_Qualifier 1522 1529	grado 4
R60	Has_Quantifier_or_Qualifier Arg1:T86 Arg2:T87	
T88	CONC 1577 1590	momento basal
#78	AnnotatorNotes T88	C1442488; Baseline; Quantitative Concept
R61	Overlap Arg1:T34 Arg2:T88	
R62	Overlap Arg1:T86 Arg2:T88	
T89	Result_or_Value 1604 1649	≥ 3 veces el límite superior de la normalidad
R63	Has_Result_or_Value Arg1:T43 Arg2:T89	
R64	Has_Result_or_Value Arg1:T44 Arg2:T89	
T90	Result_or_Value 1667 1713	≥1.5 veces el límite superior de la normalidad
R65	Has_Result_or_Value Arg1:T45 Arg2:T90	
R31	Overlap Arg1:T23 Arg2:T79	
A20	Experiencer T47 Patient
A21	Experiencer T48 Patient
A22	Experiencer T62 Patient
